Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery

Recombinant derivatives of botulinum neurotoxins engineered for trafficking studies and neuronal delivery

US Patent 8980284 · Granted Mar 17, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VH2024
Propeptide fusion comprising a mutated clostridium botulinum neurotoxin and a VH2024
Quantifying local inflammatory activity and its use to predict disease progressi2018
Treatment methods using atoxic neurotoxin derivatives2016
Treatment methods using atoxic neurotoxin derivatives2016
Quantifying local inflammatory activity and its use to predict disease progressi2014
Genetically engineered clostridial genes, proteins encoded by the engineered gen2014
Genetically engineered clostridial genes, proteins encoded by the engineered gen2014
Biocompatible materials containing stable complexes of TSG-6 and hyaluronan and 2013
Biocompatible materials containing stable complexes method of TSG-6 and hyaluron2012
Genetically engineered clostridial genes, proteins encoded by the engineered gen2011
Genetically engineered clostridial genes, proteins encoded by the engineered gen2011